Alberto Bardelli

Professor Alberto Bardelli Ph.D. is a founding scientist of NeoPhore and Professor in the Department of Oncology at the University of Torino. Professor Bardelli’s research includes ground-breaking mechanistic insights into dynamic neoantigen evolution and cancer immunology, complemented by his long history of impactful studies in the genetics translational biology of personalised cancer therapy. In addition to his role in founding NeoPhore, Professor Bardelli also co-founded Horizon Discovery, Plc and he is also the President Elect of the European Association for Cancer Research (EACR).